Related Experiment Video

Updated: Jun 17, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

Supporting evidence for natural killer T cell accumulation in progressive nonalcoholic fatty liver disease?

Wing-Kin Syn, Ye Htun Oo

    Hepatology (Baltimore, Md.)
    |December 25, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Selective Harvesting of Marginating-hepatic Leukocytes
    06:53

    Selective Harvesting of Marginating-hepatic Leukocytes

    Published on: July 21, 2016

    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
    08:41

    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

    Published on: March 24, 2023

    Related Experiment Videos

    Last Updated: Jun 17, 2026

    An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
    10:17

    An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

    Published on: April 26, 2019

    Selective Harvesting of Marginating-hepatic Leukocytes
    06:53

    Selective Harvesting of Marginating-hepatic Leukocytes

    Published on: July 21, 2016

    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
    08:41

    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

    Published on: March 24, 2023

    Related Concept Videos

    Cirrhosis II: Pathophysiology01:24

    Cirrhosis II: Pathophysiology

    Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

    Articles linked to this work by shared authors, journal, and citation graph.

    Antidiabetic medications and risk of cognitive disorders in type 2 diabetes: A retrospective cohort study.

    PloS one·2026

    Artificial intelligence predicts recurrent autoimmune hepatitis after liver transplantation in a multicenter cohort study.

    Hepatology communications·2026

    Metabolic risk and metabolic dysfunction-associated steatotic liver disease and steatohepatitis in cognitive decline: A retrospective cohort study.

    PloS one·2026

    Breath-Based Diagnostics in Liver Diseases: Dynamic Assessment of Hepatic Metabolic Reserve and Liver Fibrosis.

    Gastro hep advances·2026

    Underlying MASLD-induced gut microbiome dysbiosis and intestinal inflammation are key to poor outcomes in vibriosis infections in a preclinical model.

    Gut microbes·2026

    Neuropsychiatric Symptoms After Liver Transplant for Wilson's Disease: A US-Based Multicenter Retrospective Cohort Study.

    Clinical transplantation·2026

    Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH.

    Hepatology (Baltimore, Md.)·2026

    Drug-Induced Liver Injury (DILI) in clinical trials: Views and practical updates from DILI specialists at FDA.

    Hepatology (Baltimore, Md.)·2026

    Genetic regulation of CPEB3-mediated alternative polyadenylation associated with survival of patients with hepatocellular carcinoma.

    Hepatology (Baltimore, Md.)·2026

    Beyond cirrhosis: Major adverse liver outcomes across homozygous and heterozygous Alpha-1 antitrypsin deficiency associated liver disease.

    Hepatology (Baltimore, Md.)·2026

    Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient elastography in FIB-4-based two-step algorithms for MASLD.

    Hepatology (Baltimore, Md.)·2026

    A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B.

    Hepatology (Baltimore, Md.)·2026

    IL-1α protects intestinal barrier in murine visceral leishmaniasis.

    mBio·2026

    Clonal stochasticity in early NK cell response to mouse cytomegalovirus is generated by mature subsets of varying proliferative ability.

    eLife·2026

    Amphiregulin shapes mitochondrial delivery and immune modulation by microvescicles.

    iScience·2026

    Pathogenesis and Triazole Resistance in Aspergillus fumigatus: A Narrative Review Across the Host Immune Spectrum and One Health Context.

    Infection and drug resistance·2026

    Safety and immunogenicity of inactivated human Rotavirus vaccine in young children and infants: a randomized, placebo-controlled, double-blind, phase I clinical trial.

    Nature communications·2026

    Epigenetic repression of IL-1β by C1QBP restricts Dectin-1-mediated host defense against murine invasive candidiasis.

    Nature communications·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us